Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
MVB FINANCIAL CORP (MVBF)
|
Add to portfolio |
|
|
|
| Price: |
$41.56
| | Metrics |
| OS: |
12.7
|
M
| |
10
|
% ROE
|
| Market cap: |
$529
|
M
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
$1.54
| |
27.0
|
x P/E
|
|
BVPS
|
$21.56
| |
1.93
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 135.9 | 146.0 | 144.1 | 122.2 | 88.3 | 82.8 | 82.6 | 67.3 |
| Revenue growth | -6.9% | 1.4% | 17.9% | 38.5% | 6.5% | 0.3% | 22.6% | 40.0% |
| Cost of goods sold | 76.2 | 64.6 | 66.2 | 61.0 | 50.5 | 48.2 | 48.9 | 39.5 |
| Gross profit | 59.7 | 81.5 | 77.9 | 61.2 | 37.8 | 34.6 | 33.7 | 27.9 |
| Gross margin | 43.9% | 55.8% | 54.0% | 50.1% | 42.8% | 41.8% | 40.8% | 41.4% |
| Selling, general and administrative | 24.4 | 20.5 | 15.5 | | | | | |
| Sales and marketing | | | | 1.3 | 1.1 | 1.2 | 1.3 | 1.4 |
| Research and development | 4.2 | 4.4 | 5.4 | 4.0 | 3.7 | 5.1 | 5.0 | 4.0 |
| General and administrative | 18.9 | 15.9 | 11.8 | 9.2 | 7.1 | 6.4 | 5.2 | 4.0 |
| EBIT | 20.4 | 59.4 | 64.6 | 43.1 | 22.5 | 19.0 | 19.8 | 9.4 |
| EBIT margin | 15.0% | 40.6% | 44.8% | 35.3% | 25.5% | 22.9% | 23.9% | 13.9% |
| Pre-tax income | 18.5 | 48.6 | 46.9 | 35.0 | 15.4 | 12.3 | 13.4 | 9.5 |
| Income taxes | 4.1 | 9.9 | 9.5 | 8.5 | 3.4 | 4.8 | 4.4 | 2.9 |
| Tax rate | 22.3% | 20.3% | 20.3% | 24.1% | 21.9% | 38.6% | 32.8% | 30.4% |
| Net income | 15.0 | 39.1 | 37.0 | 26.5 | 11.5 | 7.1 | 11.8 | 6.2 |
| Net margin | 11.1% | 26.8% | 25.6% | 21.7% | 13.0% | 8.5% | 14.3% | 9.3% |
| |
| Diluted EPS | $1.17 | $3.10 | $3.06 | $2.20 | $0.91 | $0.68 | $1.17 | $0.77 |
| Shares outstanding (diluted) | 12.9 | 12.6 | 12.1 | 12.0 | 12.7 | 10.4 | 10.1 | 8.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|